NCT05554302: An ongoing trial by Baptist Health South Florida
This trial is ongoing. It must report results 5 years, 1 month from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05554302 |
|---|---|
| Title | Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 10, 2023 |
| Completion date | Jan. 31, 2030 |
| Required reporting date | Jan. 31, 2031, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |